Isabelle Fournier and her team are out to change surgical oncology.
“Better surgery is associated with better prognosis and higher survival,” said Fournier, a professor at the University of Lille and co-director of a proteomics center of INSERM, the French national institute of health. Her laboratory has worked for several years on a device they call the SpiderMass that will enable surgeons to look for markers of cancer in a living patient’s tissue, during an operation. In an article in Molecular & Cellular Proteomics, the team reports on an important step toward finding protein biomarkers during surgery.
Surgery to remove a primary tumor involves a wait. After the tumor and some healthy surrounding tissue are removed, the surgical team pauses while a pathologist checks the tissue margins under a microscope. Although this process is important for preventing recurrence of the cancer, it can add up to 45 risky minutes under anesthesia.
With the new device, Fournier said, “We think that it is possible to open the way to in vivo real-time proteomics,” which could help surgeons find stray cancer cells faster, perhaps even as they make incisions.
Fournier’s device uses mass spectrometry, which measures the mass of molecules from complex mixtures. But turning an in vivo tissue sample into gas phase ions for measurements can be a challenge. Until now, no one knew how to extract ions from living tissues without doing harm.
So Fournier’s team got creative. Riffing on MALDI, an ionization strategy that uses a carrier molecule mixed with the analyte of interest, they decided to use the water that makes up a majority of human tissue as a carrier to produce a water-assisted laser desorption/ionization, or WALDI. If they could excite the water in a tiny area, it should vaporize, taking ionized organic molecules with it.
“It was an idea at the beginning, and many people thought that it would not work,” Fourier said. “Finally, we have it working beautifully.”
The team built a pulsed laser excitation device tuned to heat water precisely by causing vibration in the oxygen-hydrogen bond. In a 2016 paper, they described using this laser to ionize the outermost layer of tissue, penetrating less than one-twentieth of a millimeter. The human volunteers reported a slight tingling sensation. But the ions that appeared were mostly small molecules and lipids, which are more apt than proteins to adopt a negative charge. The team hoped to measure proteins as well.
In this new paper, Fournier and colleagues report that they have cracked the protein puzzle. By using a more sensitive mass spectrometer and looking for positively instead of negatively charged ions, they found peaks representing purified proteins they had introduced into a cow liver sample. Now that they know the proteins are detectable, the next step will be finding ways to amplify the protein signal over more abundant lipids and metabolites.
In the meantime, the device is already in use for four-legged patients. Fournier’s lab has worked with the veterinary biotech company Oncovet Clinical Research to run a pilot trial, comparing biopsies from pet dogs with sarcoma to healthy tissues. The team developed a lipidomics- and metabolomics-based classification system to robustly identify healthy, necrotic and cancerous tissues. Soon, they will introduce a prototype into a veterinary operating room. If it is successful there, Fournier said, she hopes to reach human clinics, improving tumor removal surgery to give patients better health outcomes.
The Latest on: Proteomics
via Google News
The Latest on: Proteomics
- IsoPlexis Strengthens Executive Leadership Team with Appointment of John Strahley as Chief Financial Officeron May 11, 2020 at 10:21 am
IsoPlexis, the leader in functional cellular proteomics, today announced the appointment of John Strahley as Chief Financial Officer. As ...
- Supporting the UK National Health Service during the COVID-19 crisis from an academic perspectiveon May 11, 2020 at 8:36 am
Matthias Trost is a biochemist and mass spectrometrist working at Newcastle University. He is currently leading the university’s effort in supporting the National Health Service with COVID-19 ...
- Spectrophotometers Market explored in the latest research by Agilent Technologies, Inc., Analytik Jena AG, Biochrom, Ltd., Bio-Rad Laboratories, Inc.on May 7, 2020 at 8:29 am
What is Spectrophotometers A spectrophotometer is a device that measures the amount of the intensity of light photons Spectrophotometers are an integral part of spectrometry which plays a crucial role ...
- Mérieux Equity Partners and Korys Announce the Launch of OMX Europe Venture Fund, Dedicated to Venture Investment Within the Healthcare and Nutrition Sectorson May 7, 2020 at 12:00 am
Mérieux Equity Partners and Korys announce the launch of OMX Europe Venture Fund, dedicated to venture investment in healthcare and nutrition.
- Proteomics Market Global Outlook on Key Growth Trends, Factors 2019 to 2025on May 6, 2020 at 5:19 am
While proteomics for the most part alludes to the expansive scale exploratory examination of proteins, it is regularly particularly utilized for protein refinement and mass spectrometry. The Global ...
- Proteomics-Based Approach Identifies Altered ER Domain Properties by ALS-Linked VAPB Mutationon May 6, 2020 at 2:13 am
An ER transmembrane protein, vesicle-associated membrane protein-associated protein B (VAPB), binds to several organelle-resident membrane proteins to mediate ER-organelle tethering. Mutation in ...
- Proteomics Market (2020 to 2027) – Regional Analysis and Forecasts by Treatment Type, End User and Country Set for Rapid Growth and Trend by 2027on May 5, 2020 at 3:13 am
Proteome is a whole set of proteins that is produced by means of a machine or an organism. It is able to range with exceptional time, necessities, stresses, that an organism is going via. Proteomic is ...
- Will Proteomics International Laboratories (ASX:PIQ) Spend Its Cash Wisely?on May 3, 2020 at 10:27 pm
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...
- Proteomics study finds controversial drugs could be COVID-19 antiviralson April 30, 2020 at 11:33 am
An international consortium of researchers has used protein interaction studies to identify antiviral agents that could be effective against COVID-19 and they include one controversial drug. Detailed ...
via Bing News